BE study inclusion & exclusion criteria [Design Issues]

posted by cher0424 – China, 2014-12-17 03:19 (4208 d 05:40 ago) – Posting: # 14090
Views: 16,360

❝ Well, not only ! The amount of blood collected during a BE trial is of the same order of magnitude as the volume taken during a blood donation. In the interest of subject safety, most CROs just replicate the usual timelines between two blood donations.


Your explain inspire me to think just only focus on BE study and here is one exclude criteria i quote from protocol
"Positive results for drugs of abuse (benzodiazepines, cocaines, opioids, amphetamines, cannabinoids and barbiturates) in urine during the study check-in of each period."
why just include these six drugs, the thing is our drug test plate can test out tricyclic antidepressant (TCA) and Phencyclidine (PCP) also. One subject TCA show positive in the test. In this situation what should we do test again or exclude? if test again, what's the interval is proper?

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
129 visitors (0 registered, 129 guests [including 24 identified bots]).
Forum time: 10:00 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5